Global Lactose Intolerance Treatment Market Projected To Grow Radiantly By 2030; Asserts MRFR Unleashing Industry Forecast

Pune, India, January, 2022/MRFR Press Release/- Market Research Future published a Half-Cooked research report on “Global Lactose Intolerance Treatment Market Research Report - Forecast to 2030”– Market Analysis, Scope, Progress, Trends and Forecast to 2030 .

Global Lactose Intolerance Treatment Market- Overview

Lactose intolerance is a common digestive problem which cause symptoms such as abdominal pain, bloating, diarrhoea, gas, nausea etc. due to the decreased ability to digest the sugar lactose in milk products. This problem is caused due to the lack of enzyme lactase which breaks lactose into glucose and galactose. This condition can develop at any age. In various cases it first develop in people aged 20 to 40, although babies and young children can also be affected. There are two type of lactose intolerance. The primary lactose intolerance is caused due to fall in the amount of lactase with age while secondary lactose intolerance is caused due to injury to the small intestine such as infections, celiac disease, inflammatory bowel disease etc. Lactose intolerance can also be managed by consuming live yogurt cultures containing lactobacilli and other milk fermentation products which explains why many people, though genetically lactose intolerant, are able to tolerate large quantities of milk. Plant-based milks such as soy milk, rice milk, coconut milk, oat milk, etc. are inherently lactose-free. Low-lactose or lactose-free versions of foods supplements are used for those patients who have high lactose intolerance. Patients with little or no lactase enzyme can be supplemented by artificially produced from microbes of genus Aspergillus. The enzyme, β-galactosidase, is used and is available over the counter in many countries.

The global lactose intolerance treatment market is growing at a rate of 5.90% and is expected show a similar trend during the forecast period. The falling prices of lactose free foods due to rising scalability and larger sales will also stimulate the market. The non-serious nature of the symptoms of lactose intolerance is a major constraint on the market. According to a recent study report published by the Market Research Future, the global lactose intolerance treatment market is expected to gain eminence over the forecast period. The market is forecasted to demonstrate a steady growth by 2030, surpassing its previous growth records in terms of value with a constant CAGR during the anticipated period (2022 – 2030 ).

Johnson & Johnson Services, Inc. (U.S.), National Enzyme Company(U.S.),  Vetbiochem India Private Limited (India), Scimera Partners (U.S.), Ganeden Biotech (U.S.), Daiya Foods Inc. (Canada), Arla Foods (Denmark), OMIRA GmbH (Germany), Parmalat (Italy), Valio (Finland) are some of the prominent players at the forefront of competition in the Global Lactose Intolerance Treatment Market and are profiled in MRFR Analysis. 

Global Lactose Intolerance Treatment Market –

Regional Analysis

The lactose intolerance treatment market is chiefly driven by rise in awareness and greater screening rates in the world and especially in the developed regions of North America and Europe. The exact number of people with lactose intolerance is unknown but it is estimated that about 65% of the global population suffers from lactate intolerance. It is also estimated that lactate intolerance rates vary from less than 10% in Northern Europe to as high as 95% in parts of Asia and Africa. Moreover, In the UK, lactose intolerance is more common in people of Asian or African-Caribbean descent.

Lactose intolerance treatment market is estimated to be led by the developing regions of Asia Pacific which is further estimated to be dominated by China and India. Countries of the developing world such as Indonesia, Cambodia, China, and India is expected to be fastest growing segment for the market for lactose intolerance treatment in the Asia Pacific. The presence of large populations with unmet needs and the growing screening rates is the strongest driver of growth in these markets. Thus, there is larger potential to grow in the developing regions due to less competition. The growing number of lactose screening is the strongest factor responsible for the growth of the Asia Pacific market.

The Asia Pacific regions also have higher rates of lactose intolerance as compared to the western regions. It is estimated that at least 50-70% of non-white adults and up to 20% of Caucasians suffer from lactose intolerance and experience symptoms such as flatulence, cramp abdominal pain, diarrhoea, bloating, vomiting etc. the onset of Lactose intolerance is after 5 years of age. Lactose free milk substitutes become a necessity in infants because approximately 50% of their daily calories are derived from milk.

Explore In-depth Details: Lactose Intolerance Treatment Market Research Report